Fig. 1: Downregulation of BCL11B in HCC tissues. | Cell Death & Disease

Fig. 1: Downregulation of BCL11B in HCC tissues.

From: BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity

Fig. 1

a RT-PCR detection of BCL11B mRNA expression in 20 HCC tissues and matched non-tumor liver specimens. b The protein expression of BCL11B in 20 pairs of HCC tumor tissues (T) and corresponding peritumoral tissues (P). c Comparison of the relative expression levels of BCL11B protein between metastatic and non-metastatic HCC tissues. d Representative immunohistochemistry staining on BCL11B in 189 HCC patients. e, f Kaplan–Meier analysis of the overall survival (OS) (e) and the time-to-recurrence (TTR) (f) of HCC patients in BCL11B low group and BCL11B high group; Scale bar: 100 μm.

Back to article page